EBV
Showing 1 - 25 of 793
EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV-associated Hemophagocytic Lymphohistiocytosis
- EBV Infection
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 12, 2023
EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)
Recruiting
- EBV Infection After Allogenic HSCT
- EBV-TCR-T cells
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Nov 3, 2023
EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell
Not yet recruiting
- EBV-associated Lymphomas
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
May 31, 2023
EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm
Not yet recruiting
- EBV Lymphoma
- Post-transplant Lymphoproliferative Disease (PTLD)
- Donor-derived ex-vivo expanded EBV Tscm CTL
-
Basel, Switzerland
- +7 more
Jan 25, 2023
Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and
Not yet recruiting
- Epstein-Barr Virus Infection
- +2 more
- Matrix-M1 Adjuvant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics Trial in Beijing (observational)
Not yet recruiting
- Hemophagocytic Lymphohistiocytoses
- +2 more
- observational
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Dec 22, 2022
Reveals Relationship Between gp42-IgG Epitopes and
Not yet recruiting
- Nasopharyngeal Carcinoma
- Epitope exploration
- (no location specified)
Jul 16, 2023
EBV-associated Haematologic Tumors Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed
Not yet recruiting
- EBV-associated Haematologic Neoplasms
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
Dec 4, 2022
Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)
Recruiting
- Epstein-Barr Virus Infections
- +3 more
- Nivolumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)
Not yet recruiting
- Nasopharyngeal Carcinoma
- KSD-101
-
Wuhan, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023
Nasopharyngeal Carcinoma Trial in Xuzhou (CAR-T Cell Injection, Fludarabine, cyclophosphamide)
Recruiting
- Nasopharyngeal Carcinoma
- CAR-T Cell Injection
- +2 more
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 15, 2022
EBV-positive Nasopharyngeal Carcinoma Trial in Guangzhou (Cohort A: 3.0x10^6 CAR-T cells/kg, Cohort B: 9.0x10^6CAR-T cells/kg,
Not yet recruiting
- EBV-positive Nasopharyngeal Carcinoma
- Cohort A: 3.0x10^6 CAR-T cells/kg
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 16, 2023
CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)
Not yet recruiting
- CMV Infection
- +2 more
- Virus specific T cells
- (no location specified)
Oct 4, 2023
Malignant Tumor Trial in Chendu (EBV immunological agent)
Recruiting
- Malignant Tumor
- EBV immunological agent
-
Chendu, Sichuan, ChinaWest China Hospital
Jan 31, 2023
HLH Trial in Beijing (Thiotepa)
Recruiting
- HLH
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
May 10, 2023
EBV, Epstein-Barr Virus Infection, Infectious Mononucleosis Trial run by the NIAID (EBV gp350-Ferritin Vaccine, Matrix-M1)
Recruiting
- EBV
- +2 more
- EBV gp350-Ferritin Vaccine
- Matrix-M1
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 11, 2022
Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)
Not yet recruiting
- Nasopharyngeal Carcinoma
- PK Blood Collection
- +2 more
- (no location specified)
Nov 1, 2022
Saliva EBV-DNA Detection in EBV Infection Related Diseases
Recruiting
- EBV Infection
- Saliva Testing
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 30, 2022
Epstein-Barr Virus Infection moniToring in renAl Transplant
Recruiting
- EBV Infection
- +3 more
- EBV DNA in whole blood and plasma
-
Aarhus, Central Region Denmark, Denmark
- +2 more
Dec 12, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Malignant Tumors Trial in Chengdu (EBV mRNA vaccine)
Recruiting
- Malignant Tumors
- EBV mRNA vaccine
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jan 27, 2023
EBV-positive Gastric Cancer and Multiple Genes Associated With
Completed
- Gastric Cancer
- +2 more
- Gastrectomy
-
Suwon, Gyeong-Gi-Do, Korea, Republic ofJiwon Seo
Oct 28, 2022
Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)
Recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +2 more
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Mar 6, 2023
Nasopharyngeal Carcinoma Trial in Shanghai (Radiotherapy, Cisplatin)
Recruiting
- Nasopharyngeal Carcinoma
-
Shanghai, Shanghai, ChinaFudan Universtiy Shanghai Cancer Centre
Jan 7, 2023
EBV Emia and EBV Positive PTLD After Allogenic HSCT Trial in Sanhe (EBV-TCR-T cells)
Completed
- EBV Emia and EBV Positive PTLD After Allogenic HSCT
- EBV-TCR-T cells
-
Sanhe, Hebei, ChinaHebei Yanda Ludaopei Hospital
Mar 6, 2022